Journal of Ocular Pharmacology and Therapeutics
Journal Title
- Journal of Ocular Pharmacology and Therapeutics
ISSN
- E 1557-7732 | P 1080-7683
Publisher
- Mary Ann Liebert Inc.
Listed on(Coverage)
| JCR | 1997-2023 |
|---|---|
| SJR | 1999-2020;2022-2023 |
| CiteScore | 2011-2023 |
| SCIE | 2010-2024 |
| CC | 2016-2024 |
| SCOPUS | 2017-2024 |
| MEDLINE | 2016-2024 |
| EMBASE | 2016-2024 |
Active
- Active
based on the information
- SCOPUS:2024-10
Country
- USA
Aime & Scopes
- Journal of Ocular Pharmacology and Therapeutics is the only peer-reviewed journal that combines the fields of ophthalmology and pharmacology to enable optimal treatment and prevention of ocular diseases and disorders. The Journal delivers the latest discoveries in the pharmacokinetics and pharmacodynamics of therapeutics for the treatment of ophthalmic disorders. Journal of Ocular Pharmacology and Therapeutics coverage includes: /// Glaucoma /// Cataracts /// Retinal degeneration /// Ocular infection, trauma, and toxicology /// Ocular drug delivery and biotransformation /// Ocular pharmacotherapy/clinical trials /// Ocular inflammatory and immune disorders /// Gene and cell-based therapies /// Ocular metabolic disorders /// Ocular ischemia and blood flow /// Proliferative disorders of the eye /// Eyes on Drug Discovery - written by Gary D. Novack, PhD, featuring the latest updates on drug and device pipeline developments as well as policy/regulatory changes by the FDA